Bioenergetic consequences of opening the ATP-sensitive K+ channel of heart mitochondria

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 280, Issue 2 49-2, 2001, Pages

  Kowaltowski, Alicia J ^a,b   Seetharaman, Subramaniam ^a   Paucek, Petr ^a   Garlid, Keith D ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Cardioprotection; Ischemiareper fusion; Myocardial injury; Potassium

Indexed keywords

ADENOSINE TRIPHOSPHATE; DIAZOXIDE; PINACIDIL; POTASSIUM CHANNEL;

ANIMAL TISSUE; ARTICLE; BIOENERGY; CALCIUM TRANSPORT; CELL RESPIRATION; CONTROLLED STUDY; HEART MITOCHONDRION; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PROTECTION; MEMBRANE POTENTIAL; MITOCHONDRIAL MEMBRANE; NONHUMAN; OXIDATIVE PHOSPHORYLATION; POTASSIUM TRANSPORT; PRIORITY JOURNAL; RAT;

EID: 0034996661     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.2001.280.2.h649     Document Type: Article

References (43)

1. Beavis AD, Brannan RD, and Garlid KD. Swelling and contraction of the mitochondrial matrix. I. A structural interpretation of the relationship between light scattering and matrix volume. J Biol Chem 260: 13424-13433, 1985.
2. + uniport in intact mitochondria by adenine nucleotides and nucleotide analogs. J Biol Chem 268: 997-1004, 1993.
3. Brierley GP. Passive permeability and energy-linked ion movements in isolated heart mitochondria. Ann NY Acad Sci 227: 398-411, 1974.
4. + channels protect the myocardium against ischemia/reperfusion damage. Circ Res 69: 571-581, 1991.
5. Das DK, Maulik N, Sato M, and Ray PS. Reactive oxygen species function as second messenger during ischemic preconditioning of heart. Mol Cell Biochem 196: 59-67, 1999.
6. ATP channel in preservation of mitochondrial function. Am J Physiol Heart Circ Physiol 278: H305-H312, 2000.
7. + exchanger. J Biol Chem 255: 11273-11279, 1980.
8. Garlid KD. Mitochondrial volume control. In: Integration of Mitochondrial Function. New York: Plenum, 1988, p. 257-276.
9. Garlid KD. Cation transport in mitochondria - the potassium cycle. Biochim Biophys Acta 1275: 123-126, 1996.
10. Garlid KD and Beavis AD. Swelling and contraction of the mitochondrial matrix. II. Quantitative application of the light scattering technique to solute transport across the inner membrane. J Biol Chem 260: 13434-13441, 1985.
11. Garlid KD, Beavis AD, and Ratkje SK. On the nature of ion leaks in energy-transducing membranes. Biochim Biophys Acta 976: 109-120, 1989.
12. Garlid KD and Nakashima RA. Studies on the mechanism of uncoupling by amine local anesthetics. Evidence for mitochondrial proton transport mediated by lipophilic ion pairs. J Biol Chem 258: 7974-7980, 1983.
13. + channels. Possible mechanism of cardioprotection. Circ Res 81: 1072-1082, 1997.
14. ATP channel as a receptor for potassium channel openers. J Biol Chem 271: 8796-8769, 1996.
15. Gross GJ and Auchampach JA. Role of ATP-dependent potassium channels in myocardial ischaemia. Cardiovasc Res 26: 1011-1016, 1992.
16. Grover GJ. Protective effects of ATP-sensitive potassium-channel openers in experimental myocardial ischemia. J Cardiovasc Pharmacol 24: S18-S27, 1994.
17. Grover GJ and Garlid KD. ATP-sensitive potassium channels: a review of their cardioprotective pharmacology. J Mol Cell Cardiol 32: 677-695, 2000.
18. Grover GJ, McCullough JR, Henry DE, Conder ML, and Sleph PG. Anti-ischemic effects of the potassium channel activators pinacidil and cromakalim and the reversal of these effects with the potassium channel blocker glyburide. J Pharmacol Exp Ther 251: 98-104, 1989.
19. Grover GJ, Newburger J, Sleph PG, Dzwonczyk S, Taylor SC, Ahmed SZ, and Atwal KS. Cardioprotective effects of the potassium channel opener cromakalim: stereoselectivity and effects on myocardial adenine nucleotides. J Pharmacol Exp Ther 257: 156-162, 1991.
20. 1 receptors. Circulation 86: 1310-1316, 1992.
21. Grover GJ, Sleph PG, Dzwonczyk S, Malone HJ, and Behling RW. Glyburide-reversible cardioprotective effects of BMS-180448: functional and energetic considerations. J Cardiovasc Pharmacol 29: 28-38, 1997.
22. Gunter KK and Gunter TE. Transport of calcium by mitochondria. J Bioenerg Biomembr 26: 471-485, 1994.
23. Halestrap AP. The regulation of the matrix volume of mammalian mitochondria in vivo and in vitro and its role in the control of mitochondrial metabolism. Biochim Biophys Acta 973: 355-382, 1989.
24. + channels modulate cardiac mitochondrial function. Am J Physiol Heart Circ Physiol 275: H1567-H1576, 1998.
25. 2+ overload in rat cardiac mitochondria. J Physiol (Lond) 519: 347-360, 1999.
26. ATP channel by glyburide and 5-hydroxydecanoate. J Biol Chem 273: 13578-13582, 1998.
27. Jensen BD, Gunter KK, and Gunter TE. The efficiencies of the component steps of oxidative phosphorylation. II. Experimental determination of the efficiencies in mitochondria and examination of the equivalence of membrane potential and pH gradient in phosphorylation. Arch Biochem Biophys 248: 305-323, 1986.
28. Kay L, Rossi A, and Saks V. Detection of early ischemic damage by analysis of mitochondrial function in skinned fibers. Mol Cell Biochem 174: 79-85, 1997.
29. Liu Y, Sato T, Seharaseyon J, Szewczyk A, O'Rourke B, and Marban E. Mitochondrial ATP-dependent potassium channels. Viable candidate effectors of ischemic preconditioning. Ann NY Acad Sci 874: 27-37, 1999.
30. Mitchell P. Chemiosmotic Coupling in Oxidative and Photosynthetic Phosphorylation. Bodmin, UK: Glynn Research Laboratory, 1966, p. 155-156.
31. Nakano A, Cohen MV, and Downey JM. Ischemic preconditioning from basic mechanisms to clinical applications. Pharmacol Ther 86: 263-275, 2000.
32. ATP channel activating agent. Cardiovasc Drug Rev 18: 25-46, 2000.
33. Saks VA, Dos Santos P, Gellerich FN, and Diolez P. Quantitative studies of enzyme-substrate compartmentation, functional coupling and metabolic channelling in muscle cells. Mol Cell Biochem 184: 291-307, 1998.
34. Saks VA, Khuchua ZA, Kuznetsov AV, Veksler VI, and Sharov VG. Heart mitochondria in physiological salt solution: not ionic strength but salt composition is important for association of creatine kinase with the inner membrane surface. Biochem Biophys Res Commun 139: 1262-1271, 1986.
35. Saks VA, Khuchua ZA, Vasilyeva EV, Belikova OY, and Kuznetsov AV. Metabolic compartmentation and substrate channelling in muscle cells. Mol Cell Biochem 133/134: 155-192, 1994.
36. + channels by protein kinase C. Circ Res 83: 110-114, 1998.
37. ATP channels in ischemic cardioprotection. Circulation 101: 2418-2423, 2000.
38. Schafer G, Wegener C, Portenhauser R, and Bojanovski D. Diazoxide, an inhibitor of succinate oxidation. Biochem Pharmacol 18: 2678-2681, 1969.
39. Sun X and Garlid KD. On the mechanism by which bupivacaine conducts protons across the membranes of mitochondria and liposomes. J Biol Chem 267: 19147-19154, 1992.
40. Szewczyk A, Wojcik G, and Nalecz MJ. Potassium channel opener, RP 66471, induces membrane depolarization of rat liver mitochondria. Biochem Biophys Res Commun 207: 126-132, 1995.
41. Tan HL, Mazon P, Verberne HJ, Sleeswijk ME, Coronel R, Opthof T, and Janse MJ. Ischaemic preconditioning delays ischaemia-induced cellular electrical uncoupling in rabbit myocardium by activation of ATP-sensitive potassium channels. Cardiovasc Res 27: 644-651, 1993.
42. Wojtczak L, Bogucka K, Duszynski J, Zablocka B, and Zolkiewska A. Regulation of mitochondrial resting state respiration: slip, leak, heterogeneity. Biochim Biophys Acta 1018: 177-181, 1990.
43. Yang X, Pain T, Heusch G, Cohen MV, and Downey JM. Diazoxide protects the heart by release of free radicals (Abstract). J Mol Cell Cardiol 32: A49, 2000.